- Home
- EVAC vs BBNX Comparison
EVAC vs BBNX Comparison
Compare EVAC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$10.21
HOLD
Current Price
$16.97
Company Overview
Basic Information| Metric | EVAC | BBNX |
|---|---|---|
| Founded | 2024 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Fluid Controls | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 592.7M | 493.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EVAC | BBNX |
|---|---|---|
| Price | $10.21 | $16.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $23.80 |
| AVG Volume (30 Days) | 93.2K | ★ 977.2K |
| Earning Date | 01-01-0001 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $34.90 |
| Revenue Next Year | N/A | $34.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $8.80 |
| 52 Week High | $10.23 | $32.71 |
Technical Indicators
Market Signals| Indicator | EVAC | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 62.30 | 64.44 |
| Support Level | $10.16 | $16.02 |
| Resistance Level | $10.23 | $32.52 |
| Average True Range (ATR) | 0.02 | 1.07 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 85.72 | 63.14 |
Price Performance
Historical Comparison EVAC
BBNX
About EVAC EQV Ventures Acquisition Corp. II Class A Ordinary Shares
EQV Ventures Acquisition Corp II is a blank check company.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.